ScreenerHero

PLTHPlanet 13 Holdings Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · planet13.com
0.1850CAD-13.95%Mkt Cap: 45.18M $P/E: —

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States. It owns, manufactures, and sells canna…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$62.66BUSDP/E 24.3
TAK
Takeda Pharmaceutical Company Limited
$60.33BUSD
TEVA
Teva Pharmaceutical Industries Limited
$46.72BUSDP/E 66.8
HLN
Haleon plc
$41.16BUSDP/E 19.5
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.6
ZOE
Zoetis Inc.
$27.77BUSDP/E 11.6
UTHR
United Therapeutics Corporation
$21.22BUSDP/E 17.7
VTRS
Viatris, Inc.
$19.47BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.80BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.63BUSDP/E 21.0
IPN
Ipsen S.A.
$13.27BUSDP/E 24.0
ELAN
Elanco Animal Health Incorporated
$11.20BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.33BUSDP/E 30.2
KRK
Krka, d. d.
$8.66BUSDP/E 18.8
ALKS
Alkermes plc
$7.41BUSDP/E 116.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.02BUSDP/E 42.0
HIMS
Hims & Hers Health, Inc.
$6.85BUSD
LNTH
Lantheus Holdings, Inc.
$6.55BUSDP/E 24.0
KNSA
Kiniksa Pharmaceuticals International, plc
$6.10BUSDP/E 78.9
LQDA
Liquidia Corporation
$5.95BUSDP/E 47.5

Key Statistics

Company
Market Cap45.18M $
Enterprise Value79.64M $
Revenue (TTM)67.32M $
Gross Profit29.04M $
Net Income (TTM)-46.55M $
Revenue/Share0.2054 USD
Last Price0.1850 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees650
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.68
PEG—
EV/EBITDA-6.82
EV/Revenue1.18
P/S0.67
P/B1.14
EPS (TTM)-0.27
EPS (Forward)-0.11
52W Range
0.15508% of range0.5500
52W High0.5500 CAD
52W Low0.1550 CAD
Profitability
Gross Margin38.57%
Oper. Margin-16.99%
EBITDA Margin-17.35%
Profit Margin-61.83%
ROE-125.03%
ROA-41.98%
Growth
Revenue Growth-14.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.34M $
CapEx (TTM)4.79M $
FCF Margin-8.98%
FCF Yield-13.38%
Net Debt34.46M $
Net Debt/EBITDA-2.95
Balance Sheet
Debt/Equity1.06
Current Ratio1.80
Quick Ratio0.41
Book Value/Sh0.1624 CAD
Cash/Share0.0200 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.2584 CAD
Upside (mean)+39.7%
Target Range0.2115 CAD – 0.3053 CAD
CAD0.2115+39.7% to meanCAD0.3053
# Analysts2
Ownership
Shares Out.335.32M
Float238.85M
Insiders28.23%
Institutions0.49%
Short Interest
Short Ratio0.1d
Short % Float0.00%
Short % Out.0.00%
Shares Short9.62K
Short (prev mo.)7.13K
Technical
SMA 500.1848 (+0.1%)
SMA 2000.2158 (-14.3%)
Beta1.74
S&P 52W Chg14.29%
Avg Vol (30d)80.85K
Avg Vol (10d)41.96K
Technical Indicators
RSI (14)65.6
MACD0.0073
MACD Signal0.0025
MACD Hist.+0.0048
BB Upper0.2166 CAD
BB Middle0.1805 CAD
BB Lower0.1444 CAD
BB Width40.02%
ATR (14)0.0128 CAD
Vol Ratio (20d)2.07x